Koumine
Koumine is a research compound with potential therapeutic applications in diabetic neuropathy, breast cancer, and pain management. Its analgesic effects in rodent models are linked to increased spinal allopregnanolone, while in vitro studies suggest antineoplastic activity.
Product Specifications
CAS Number
1358-76-5
Product Name Alternative
Koumine, inhibit, Inhibitor
Field of Research
Cell Biology
Purity
98.00% (May vary between batches)
Solubility
DMSO:14.00 mg/mL (45.69 mM) ; Chloroform, Dichloromethane, Ethyl Acetate, Acetone, etc.:Soluble;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2.00 mg/mL (6.53 mM)
Smiles
[H][C@]12C[C@]3 ([H]) [C@] ([H]) (CO1) [C@]1 ([H]) C[C@]4 (C2=Nc2ccccc42) [C@]3 (CN1C) C=C
Molecular Formula
C20H22N2O
Molecular Weight
306.40
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1350438-01 0.02 mg (E-Coli)
Recombinant Caenorhabditis elegans GTP-binding protein SAR1 (ZK180.4)
Sign In for Pricing
View Details 
MBS1350438-02 0.1 mg (E-Coli)
Recombinant Caenorhabditis elegans GTP-binding protein SAR1 (ZK180.4)
Sign In for Pricing
View Details MBS1350438-03 0.02 mg (Yeast)
Recombinant Caenorhabditis elegans GTP-binding protein SAR1 (ZK180.4)
Sign In for Pricing
View Details MBS1350438-04 0.1 mg (Yeast)
Recombinant Caenorhabditis elegans GTP-binding protein SAR1 (ZK180.4)
Sign In for Pricing
View Details MBS1350438-05 0.02 mg (Baculovirus)
Recombinant Caenorhabditis elegans GTP-binding protein SAR1 (ZK180.4)
Sign In for Pricing
View Details 
MBS1350438-06 0.02 mg (Mammalian-Cell)
Recombinant Caenorhabditis elegans GTP-binding protein SAR1 (ZK180.4)
Sign In for Pricing
View Details